Demonstrating Therapeutic Equivalence for Generic Topical Products

2 years ago

Our Chief Technical Officer, Rob Harris discusses how the determination of topical bioequivalence requires a multi-faceted approach, tailored specifically to the generic-drug formulation in this article as featured in Pharmaceutical Technology entitled ‘Demonstrating Therapeutic Equivalence for Generic Topical Products’.

You can read full article online via PharmTech.com.

Rob Harris